Literature DB >> 12890708

Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.

Melanie Madhani1, Ramona S Scotland, Raymond J MacAllister, Adrian J Hobbs.   

Abstract

(1) The sensitivity of the particulate guanylate cyclase-cyclic guanosine-3',5'-monophosphate (cGMP) system to atrial (ANP) and C-type (CNP) natriuretic peptides was investigated in aortae and mesenteric small arteries from wild-type (WT) and endothelial nitric oxide synthase (eNOS) knockout (KO) mice. (2) ANP and CNP produced concentration-dependent relaxations of mouse aorta that were significantly attenuated by the natriuretic peptide receptor (NPR)-A/B antagonist HS-142-1 (10(-5) M). Both ANP and CNP were more potent in aortae from eNOS KO mice compared to WT. (3) The potency of ANP and CNP in aortae from WT animals was increased in the presence of the NOS inhibitor, N(G)-nitro-L-arginine (3 x 10(-4) M) and the soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolol[4,3,a]quinoxalin-1-one (5 x 10(-6) M). (4) In contrast, the potency of ANP and CNP in aortae from eNOS KO animals was reduced following pretreatment of tissues with supramaximal concentrations of the NO-donor, glyceryl trinitrate (3 x 10(-5) M, 30 min) or ANP (10(-7) M, 30 min). (5) Responses to acetylcholine in aortae from WT mice (dependent on the release of endothelium-derived NO) were significantly reduced following pretreatment of tissues with GTN (3 x 10(-5) M, 30 min) and ANP (10(-7) M, 30 min). (6) CNP and the NO-donor, spermine-NONOate caused concentration-dependent relaxations of mesenteric small arteries from WT animals that were significantly increased in eNOS KO mice compared to WT. ANP was unable to significantly relax mesenteric arteries from WT or eNOS KO animals. (7) In conclusion, both NPR-A- and NPR-B-linked pGC pathways are modulated by NO-cGMP in murine aorta and mesenteric small arteries and crossdesensitisation occurs between NPR subtypes. The biological activity of endothelium-derived NO is also influenced by the ambient concentration of NO and natriuretic peptides. Such an autoregulatory pathway may represent an important physiological homeostatic mechanism and link the paracrine activity of NO and CNP with the endocrine functions of ANP and BNP in the regulation of vascular tone and blood pressure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890708      PMCID: PMC1573960          DOI: 10.1038/sj.bjp.0705365

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

Review 2.  Molecular biology of natriuretic peptides and nitric oxide synthases.

Authors:  B C Kone
Journal:  Cardiovasc Res       Date:  2001-08-15       Impact factor: 10.787

Review 3.  The renal urodilatin system: clinical implications.

Authors:  W Forssmann; M Meyer; K Forssmann
Journal:  Cardiovasc Res       Date:  2001-08-15       Impact factor: 10.787

4.  Evidence for phosphorylation of rat brain guanylate cyclase by cyclic AMP-dependent protein kinase.

Authors:  J Zwiller; M O Revel; P Basset
Journal:  Biochem Biophys Res Commun       Date:  1981-08-31       Impact factor: 3.575

5.  Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C).

Authors:  K S Murthy; G M Makhlouf
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

6.  Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.

Authors:  M B Hussain; A J Hobbs; R J MacAllister
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

7.  Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases.

Authors:  M B Hussain; R J MacAllister; A J Hobbs
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

8.  Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation.

Authors:  R Ferrero; F Rodríguez-Pascual; M T Miras-Portugal; M Torres
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

Review 9.  C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.

Authors:  H H Chen; J C Burnett
Journal:  J Cardiovasc Pharmacol       Date:  1998       Impact factor: 3.105

10.  Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.

Authors:  R J Winquist; E P Faison; S A Waldman; K Schwartz; F Murad; R M Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more
  27 in total

Review 1.  Natriuretic peptide C receptor signalling in the heart and vasculature.

Authors:  Robert A Rose; Wayne R Giles
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 2.  Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle.

Authors:  Manuel Morgado; Elisa Cairrão; António José Santos-Silva; Ignacio Verde
Journal:  Cell Mol Life Sci       Date:  2011-09-27       Impact factor: 9.261

3.  Reciprocal regulation of human soluble and particulate guanylate cyclases in vivo.

Authors:  M Madhani; M Okorie; A J Hobbs; R J MacAllister
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

4.  Preservation of nitric oxide-induced relaxation of porcine coronary artery: roles of the dimers of soluble guanylyl cyclase, phosphodiesterase type 5, and cGMP-dependent protein kinase.

Authors:  Juan Liu; Zhengju Chen; Liping Ye; Huixia Liu; Dou Dou; Limei Liu; Xiaoxing Yu; Yuansheng Gao
Journal:  Pflugers Arch       Date:  2014-01-12       Impact factor: 3.657

5.  Influence of regular physical activity and caloric restriction on β-adrenergic and natriuretic peptide receptor expression in retroperitoneal adipose tissue of OLETF rats.

Authors:  Nathan T Jenkins; Jaume Padilla; R Scott Rector; M Harold Laughlin
Journal:  Exp Physiol       Date:  2013-07-05       Impact factor: 2.969

6.  Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity.

Authors:  William J Perkins; David O Warner; Keith A Jones
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

7.  Resistance to endotoxic shock in mice lacking natriuretic peptide receptor-A.

Authors:  Catherine M Panayiotou; Reshma Baliga; Raymond Stidwill; Valerie Taylor; Mervyn Singer; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

8.  Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.

Authors:  Reshma S Baliga; Lan Zhao; Melanie Madhani; Belen Lopez-Torondel; Cristina Visintin; David Selwood; Martin R Wilkins; Raymond J MacAllister; Adrian J Hobbs
Journal:  Am J Respir Crit Care Med       Date:  2008-08-08       Impact factor: 21.405

9.  Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.

Authors:  Inmaculada C Villar; Catherine M Panayiotou; Adil Sheraz; Melanie Madhani; Ramona S Scotland; Muriel Nobles; Barbara Kemp-Harper; Amrita Ahluwalia; Adrian J Hobbs
Journal:  Cardiovasc Res       Date:  2007-03-03       Impact factor: 10.787

10.  Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.